Center for Scientific Review; Notice of Closed Meetings, 1356-1357 [2016-31919]
Download as PDF
1356
Federal Register / Vol. 82, No. 3 / Thursday, January 5, 2017 / Notices
Workers’ Compensation Programs
Performance Measures as it relates to
the Black Lung Program, (2) to submit
documents relevant to active Black Lung
benefits claims electronically into
Claimant Online Access Link (C.O.A.L.)
and (3) to follow other procedures and
training related to diagnostic and
medical providers. This last point
encompasses the learning modules
entitled ‘‘Black Lung Disability
Evaluation and Claims Training for
Medical Examiners’’ and available at
https://www.publichealthlearning.com/
course/category.php?id=35. HRSA will
continue to work with DOL and BLCP
awardees to strengthen this component
of the BLCP.
Pulmonary Rehabilitation
Summary of Comments
All of the commenters agreed that
onsite pulmonary rehabilitation is a
vital service. However, most
commenters expressed concerns that
this service is not widely available to
miners who need it because it is costly
to operate, there are low rates of
reimbursement, and miners often aren’t
able to travel to clinics that do offer
treatment. Some commenters said that
consideration should be given for nontraditional pulmonary treatment
programs, such as in-home treatments,
and that HRSA should further research
the effectiveness of these programs. A
few commenters argued that BLCP
clinics should collaborate more with
hospital-based pulmonary rehabilitation
programs in multiple communities to
make it more feasible for miners to
receive treatment. Nearly all of the
commenters expressed concerns that
American Association of Cardiovascular
and Pulmonary Rehabilitation
(AACVPR) certification is difficult to
obtain and financially burdensome to
the clinics, and that it is not costeffective for the clinic to try to meet this
standard for additional grant funding.
Geographic Boundaries
Summary of Comments
A few commenters expressed concern
over how HRSA defines the service
areas of each clinic. At least two noted
that in some cases, coal miners work or
reside in closer proximity to clinics in
neighboring states than to those within
the same state, but that HRSA limits
clinics’ ability to conduct outreach in
other states. Another commenter stated
that some clinics provide
complementary services in close
proximity to one another.
Response
In certain cases, the FY 2017 BLCP
FOA allows more than one BLCP
awardee to provide services to coal
miners in a given county, provided
those awardees detail how they will
avoid duplicating efforts of other black
lung clinics. Applicants may also
propose to provide services (including
outreach) to coal miners in counties
other than the ones listed in the FY
2017 BLCP FOA, including counties in
neighboring states, provided that they
demonstrate how their services will
complement—rather than duplicate—
existing efforts in those counties. A coal
miner may receive services at a black
lung clinic of his or her choosing,
regardless of that clinic’s location or
service area designation.
Conclusion
HRSA considers many of the
comments received to be useful and
informative to future discussions on
how to strengthen the BLCP in future
years and appreciates the interest and
dedication of the commenters who are
committed to serving U.S. coal miners.
Any questions or concerns should be
directed to Blacklung@hrsa.gov.
Diana Espinosa,
Deputy Administrator.
[FR Doc. 2016–32003 Filed 1–4–17; 8:45 am]
BILLING CODE 4165–15–P
mstockstill on DSK3G9T082PROD with NOTICES
Response
In the FY 2014 BLCP FOA, BLCP
awardees receiving the highest level of
funding were required to provide
AACVPR-certified pulmonary
rehabilitation programs onsite. The FY
2017 BLCP FOA removes this
requirement and instead requires all
applicants to propose, at a minimum,
onsite, contracted, or referral to
accredited Phase II or Phase III
pulmonary rehab services. BLCP
awardees providing AACVPR-certified
programs to coal miners may maintain
their certification if they choose, but
this is no longer a requirement.
VerDate Sep<11>2014
21:06 Jan 04, 2017
Jkt 241001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Delegation of Authority Under Title III,
Part D, Section 340B(d)(1)(B)(vi) of the
Public Health Service Act (PHSA)
Notice is hereby given that I have
delegated to the Inspector General,
Office of Inspector General, the
authority vested in the Secretary of
Health and Human Services under Title
III, Part D, Section 340B(d)(1)(B)(vi) of
the Public Health Service Act (PHSA),
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
as amended, to impose sanctions in the
form of civil monetary penalties against
manufacturers that knowingly and
intentionally charge a 340B covered
entity a price for purchase of a drug that
exceeds the maximum applicable
ceiling price as defined by section
340B(a)(1) of the PHSA. In accordance
with section 340B(d)(1)(B)(vi)(II) of the
PHSA, such sanctions shall not exceed
$5,000 for each instance of overcharging
a 340B covered entity that may have
occurred. This authority may be
redelegated. This delegation excludes
the authority to issue regulations.
I have affirmed and ratified any
actions taken by the Inspector General,
or subordinates, that involved the
exercise of the authority delegated
herein prior to the effective date of the
delegation.
This delegation became effective upon
date of signature.
Authority: 42 U.S.C. 256b(d)(1)(B)(vi)
Sylvia M. Burwell,
Secretary, Department of Health and Human
Services.
[FR Doc. 2016–31944 Filed 1–4–17; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Psychosocial Risk and Disease Prevention
Study Section.
Date: January 23–24, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westgate Hotel, 1055 Second
Avenue, San Diego, CA 92101.
Contact Person: Stacey FitzSimmons,
Ph.D., MPH, Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114,
E:\FR\FM\05JAN1.SGM
05JAN1
Federal Register / Vol. 82, No. 3 / Thursday, January 5, 2017 / Notices
MSC 7808, Bethesda, MD 20892, (301) 451–
9956, fitzsimmonss@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR16–304:
Behavioral and Psychological Phenotypes
Contributing to Obesity.
Date: January 24, 2017.
Time: 5:30 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westgate Hotel, 1055 Second
Avenue, San Diego, CA 92101.
Contact Person: Stacey FitzSimmons,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114,
MSC 7808, Bethesda, MD 20892, 301–451–
9956, fitzsimmonss@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 29, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–31919 Filed 1–4–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
mstockstill on DSK3G9T082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Rapid Assessment of Zika
Virus (ZIKV) Complications (R21).
Date: January 31, 2017.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
3E61, 5601 Fishers Lane, Rockville, MD
20892 (Telephone Conference Call).
Contact Person: Raymond R. Schleef,
Ph.D., Senior Scientific Review Officer,
Scientific Review Program, Division of
VerDate Sep<11>2014
21:06 Jan 04, 2017
Jkt 241001
Extramural Activities, Room 3E61, National
Institutes of Health/NIAID, 5601 Fishers
Lane, MSC 9823, Bethesda, MD 20892–9823,
(240) 669–5019, schleefrr@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 29, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–31985 Filed 1–4–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Pathophysiological Basis of Mental
Disorders and Addictions Study Section.
Date: February 1–2, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Boris P. Sokolov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217A,
MSC 7846, Bethesda, MD 20892, 301–408–
9115, bsokolov@csr.nih.gov.
Name of Committee: Immunology
Integrated Review Group; Transplantation,
Tolerance, and Tumor Immunology Study
Section.
Date: February 2–3, 2017.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Pier 2620 Fishman’s Wharf Hotel,
2620 Jones Street, San Francisco, CA 94133.
Contact Person: Jin Huang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4199,
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
1357
MSC 7812, Bethesda, MD 20892, 301–435–
1230, jh377p@nih.gov.
Name of Committee: Immunology
Integrated Review Group; Hypersensitivity,
Autoimmune, and Immune-mediated
Diseases Study Section.
Date: February 2–3, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications
Place: Argonaut Hotel, 495 Jefferson Street,
San Francisco, CA 94109.
Contact Person: Deborah Hodge, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4207
MSC 7812, Bethesda, MD 20892, (301) 435–
1238, hodged@mail.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Clinical Molecular
Imaging and Probe Development.
Date: February 2–3, 2017.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Donald Scott Wright,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
MSC 7854, Bethesda, MD 20892, (301) 435–
8363, wrightds@csr.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group,
Clinical, Integrative and Molecular
Gastroenterology Study Section.
Date: February 2, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Lorien Hotel & Spa, 1600 King
Street, Alexandria, VA 22314.
Contact Person: Jonathan K. Ivins, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2190,
MSC 7850, Bethesda, MD 20892, (301) 594–
1245, ivinsj@csr.nih.gov.
Name of Committee: Vascular and
Hematology Integrated Review Group;
Atherosclerosis and Inflammation of the
Cardiovascular System Study Section.
Date: February 2–3, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Long Beach and Executive
Center, 701 West Ocean Boulevard, Long
Beach, CA 90831.
Contact Person: Natalia Komissarova,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207,
MSC 7846, Bethesda, MD 20892, 301–435–
1206, komissar@mail.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Psychosocial Development, Risk and
Prevention Study Section.
Date: February 2–3, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\05JAN1.SGM
05JAN1
Agencies
[Federal Register Volume 82, Number 3 (Thursday, January 5, 2017)]
[Notices]
[Pages 1356-1357]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31919]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Risk, Prevention and Health Behavior
Integrated Review Group; Psychosocial Risk and Disease Prevention
Study Section.
Date: January 23-24, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Westgate Hotel, 1055 Second Avenue, San Diego, CA
92101.
Contact Person: Stacey FitzSimmons, Ph.D., MPH, Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114,
[[Page 1357]]
MSC 7808, Bethesda, MD 20892, (301) 451-9956,
fitzsimmonss@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR16-304: Behavioral and Psychological Phenotypes
Contributing to Obesity.
Date: January 24, 2017.
Time: 5:30 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Westgate Hotel, 1055 Second Avenue, San Diego, CA
92101.
Contact Person: Stacey FitzSimmons, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114, MSC 7808, Bethesda, MD
20892, 301-451-9956, fitzsimmonss@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: December 29, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-31919 Filed 1-4-17; 8:45 am]
BILLING CODE 4140-01-P